Robeco Institutional Asset Management B.V. Increases Stock Holdings in DocuSign, Inc. (NASDAQ:DOCU)

Robeco Institutional Asset Management B.V. increased its holdings in DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 7.1% in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 1,296,517 shares of the company's stock after buying an additional 85,987 shares during the quarter. Robeco Institutional Asset Management B.V. owned about 0.64% of DocuSign worth $80,501,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Jericho Capital Asset Management L.P. lifted its holdings in DocuSign by 316.6% in the first quarter. Jericho Capital Asset Management L.P. now owns 3,417,908 shares of the company's stock valued at $203,536,000 after acquiring an additional 2,597,489 shares during the period. Thrivent Financial for Lutherans bought a new position in shares of DocuSign in the 2nd quarter worth approximately $115,795,000. Pacer Advisors Inc. boosted its holdings in shares of DocuSign by 77.9% in the second quarter. Pacer Advisors Inc. now owns 3,519,969 shares of the company's stock worth $188,318,000 after buying an additional 1,541,816 shares during the last quarter. Renaissance Technologies LLC grew its position in DocuSign by 18.3% during the second quarter. Renaissance Technologies LLC now owns 3,729,314 shares of the company's stock valued at $199,518,000 after buying an additional 576,414 shares during the period. Finally, Skandinaviska Enskilda Banken AB publ increased its holdings in DocuSign by 151.3% during the second quarter. Skandinaviska Enskilda Banken AB publ now owns 865,872 shares of the company's stock valued at $46,324,000 after buying an additional 521,292 shares during the last quarter. Institutional investors own 77.64% of the company's stock.

Insider Activity at DocuSign

In related news, insider Robert Chatwani sold 14,799 shares of the firm's stock in a transaction dated Wednesday, September 18th. The shares were sold at an average price of $55.46, for a total value of $820,752.54. Following the transaction, the insider now owns 70,748 shares of the company's stock, valued at $3,923,684.08. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In other DocuSign news, CEO Allan C. Thygesen sold 7,764 shares of the stock in a transaction on Friday, November 1st. The stock was sold at an average price of $69.95, for a total transaction of $543,091.80. Following the sale, the chief executive officer now owns 107,825 shares of the company's stock, valued at approximately $7,542,358.75. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Robert Chatwani sold 14,799 shares of the business's stock in a transaction on Wednesday, September 18th. The stock was sold at an average price of $55.46, for a total value of $820,752.54. Following the completion of the transaction, the insider now directly owns 70,748 shares of the company's stock, valued at approximately $3,923,684.08. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 69,558 shares of company stock worth $4,272,768 in the last quarter. 1.66% of the stock is owned by company insiders.

DocuSign Stock Up 3.3 %

NASDAQ DOCU traded up $2.33 on Tuesday, reaching $72.18. The company had a trading volume of 1,012,462 shares, compared to its average volume of 2,895,170. The firm's 50 day moving average price is $63.38 and its 200 day moving average price is $58.13. DocuSign, Inc. has a 12 month low of $39.65 and a 12 month high of $73.80. The stock has a market capitalization of $14.65 billion, a PE ratio of 14.82, a price-to-earnings-growth ratio of 7.52 and a beta of 0.90.

DocuSign (NASDAQ:DOCU - Get Free Report) last released its quarterly earnings results on Thursday, September 5th. The company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.80 by $0.17. DocuSign had a return on equity of 16.18% and a net margin of 34.56%. The business had revenue of $736.03 million during the quarter, compared to analysts' expectations of $727.20 million. During the same quarter last year, the business posted $0.09 EPS. The firm's revenue for the quarter was up 7.0% compared to the same quarter last year. On average, research analysts expect that DocuSign, Inc. will post 1.01 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on DOCU shares. JMP Securities reiterated a "market outperform" rating and set a $84.00 price target on shares of DocuSign in a research note on Thursday, September 5th. Royal Bank of Canada boosted their price target on DocuSign from $52.00 to $57.00 and gave the company a "sector perform" rating in a report on Friday, September 6th. Robert W. Baird raised their price objective on DocuSign from $55.00 to $59.00 and gave the stock a "neutral" rating in a research note on Friday, September 6th. Wells Fargo & Company boosted their price objective on DocuSign from $48.00 to $50.00 and gave the company an "underweight" rating in a research note on Friday, September 6th. Finally, Bank of America raised their target price on shares of DocuSign from $60.00 to $68.00 and gave the stock a "neutral" rating in a research note on Friday, September 6th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, DocuSign currently has a consensus rating of "Hold" and a consensus price target of $63.40.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.